Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis
被引:175
作者:
Gittler, Julia K.
论文数: 0引用数: 0
h-index: 0
机构:
Albert Einstein Coll Med, Bronx, NY 10467 USA
Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USAAlbert Einstein Coll Med, Bronx, NY 10467 USA
Gittler, Julia K.
[1
,2
]
Krueger, James G.
论文数: 0引用数: 0
h-index: 0
机构:
Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USAAlbert Einstein Coll Med, Bronx, NY 10467 USA
Krueger, James G.
[2
]
Guttman-Yassky, Emma
论文数: 0引用数: 0
h-index: 0
机构:
Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USAAlbert Einstein Coll Med, Bronx, NY 10467 USA
Guttman-Yassky, Emma
[2
,3
]
机构:
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
[3] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA
Atopic dermatitis (AD), as well as irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD), are common skin diseases. These diseases are characterized by skin inflammation mediated by activated innate immunity or acquired immune mechanisms. Although AD, ICD, and ACD can be encountered in pure forms by allergists and dermatologists, patients with AD often present with increased frequency of ICD and ACD. Although a disturbed barrier alone could potentiate immune reactivity in patients with AD through increased antigen penetration, additional immune mechanisms might explain the increased susceptibility of atopic patients to ICD and ACD. This review discusses cellular pathways associated with increased skin inflammation in all 3 conditions and presents mechanisms that might contribute to the increased rate of ICD and ACD in patients with AD. (J Allergy Clin Immunol 2013;131:300-13.)